{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T18:22:06Z","timestamp":1777141326988,"version":"3.51.4"},"reference-count":8,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["IJDVL"],"DOI":"10.25259\/ijdvl_898_2024","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T06:20:20Z","timestamp":1727677220000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paradoxical eczema in psoriasis patients following treatment with secukinumab"],"prefix":"10.25259","volume":"0","author":[{"given":"Shekhar","family":"Neema","sequence":"first","affiliation":[{"name":"Department of Dermatology, Base Hospital, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Pathania","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Base Hospital, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prathima","family":"Nyalam","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Base Hospital, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parul","family":"Kamboj","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Base Hospital, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashantha","family":"GB","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Base Hospital, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"10.25259\/IJDVL_898_2024\/ref-1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/PTT.S146004","article-title":"Secukinumab in the treatment of psoriasis: Patient selection and perspectives","volume":"8","author":"Yang","year":"2018","journal-title":"Psoriasis (Auckl)"},{"key":"10.25259\/IJDVL_898_2024\/ref-2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1159\/000513467","article-title":"Atopic dermatitis as a paradoxical effect of secukinumab for the treatment of psoriasis","volume":"13","author":"Mendes Roncada","year":"2021","journal-title":"Case Rep Dermatol"},{"key":"10.25259\/IJDVL_898_2024\/ref-3","doi-asserted-by":"publisher","first-page":"e12751","DOI":"10.1111\/dth.12751","article-title":"Atopic-like dermatitis after secukinumab injection: A case report","volume":"32","author":"Burlando","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.25259\/IJDVL_898_2024\/ref-4","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/jdv.16246","article-title":"Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: A systematic review","volume":"34","author":"Al-Janabi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.25259\/IJDVL_898_2024\/ref-5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/09546634.2016.1230173","article-title":"Eczema as an adverse effect of anti-TNF\u03b1 therapy in psoriasis and other Th1-mediated diseases: A review","volume":"28","author":"Nakamura","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"10.25259\/IJDVL_898_2024\/ref-6","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/bjd.17779","article-title":"Eczematous eruption during anti-interleukin 17 treatment of psoriasis: An emerging condition","volume":"181","author":"Napolitano","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.25259\/IJDVL_898_2024\/ref-7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jdcr.2017.11.026","article-title":"Concurrence of psoriasis vulgaris and atopic eczema in a single patient exhibiting different expression patterns of psoriatic autoantigens in the lesional skin","volume":"4","author":"Ono","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.25259\/IJDVL_898_2024\/ref-8","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/ced.15130","article-title":"Paradoxical eczema in patients with psoriasis receiving biologics: A case series","volume":"47","author":"Al-Janabi","year":"2022","journal-title":"Clin Exp Dermatol"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/paradoxical-eczema-in-psoriasis-patients-following-treatment-with-secukinumab\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/paradoxical-eczema-in-psoriasis-patients-following-treatment-with-secukinumab\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T06:20:22Z","timestamp":1727677222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/paradoxical-eczema-in-psoriasis-patients-following-treatment-with-secukinumab\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":8,"alternative-id":["10.25259\/IJDVL_898_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_898_2024","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"article-number":"1"}}